Matthias Piesche

921 total citations
18 papers, 691 citations indexed

About

Matthias Piesche is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Matthias Piesche has authored 18 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Matthias Piesche's work include Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (3 papers). Matthias Piesche is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (3 papers). Matthias Piesche collaborates with scholars based in Chile, Germany and United States. Matthias Piesche's co-authors include Glenn Dranoff, Ingrid Carvacho, Jun Zhou, Scott J. Rodig, Xinqi Wu, Xiaoyun Liao, Anita Giobbie‐Hurder, F. Stephen Hodi, Charles Lee and Gordon J. Freeman and has published in prestigious journals such as Clinical Cancer Research, FEBS Letters and Frontiers in Immunology.

In The Last Decade

Matthias Piesche

17 papers receiving 686 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthias Piesche Chile 13 391 320 220 78 58 18 691
Yulan Qing United States 11 276 0.7× 311 1.0× 289 1.3× 45 0.6× 23 0.4× 17 698
Oihana Murillo Spain 18 544 1.4× 642 2.0× 313 1.4× 44 0.6× 102 1.8× 26 1.2k
Kumar S. Bishnupuri United States 11 307 0.8× 198 0.6× 380 1.7× 66 0.8× 116 2.0× 19 883
Justina McEvoy United States 9 246 0.6× 219 0.7× 402 1.8× 58 0.7× 35 0.6× 11 691
Neele Schumacher Germany 14 253 0.6× 259 0.8× 193 0.9× 40 0.5× 29 0.5× 17 607
Shingo Eikawa Japan 11 443 1.1× 433 1.4× 501 2.3× 72 0.9× 64 1.1× 21 987
Natasha K. Brockwell Australia 5 283 0.7× 194 0.6× 209 0.9× 97 1.2× 19 0.3× 6 585
Alaa Kassim Ali Canada 11 256 0.7× 587 1.8× 206 0.9× 40 0.5× 29 0.5× 19 780
Minghao Zhong United States 9 246 0.6× 182 0.6× 244 1.1× 34 0.4× 38 0.7× 23 499
Léa Tourneur France 14 225 0.6× 318 1.0× 472 2.1× 42 0.5× 60 1.0× 20 744

Countries citing papers authored by Matthias Piesche

Since Specialization
Citations

This map shows the geographic impact of Matthias Piesche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Piesche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Piesche more than expected).

Fields of papers citing papers by Matthias Piesche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Piesche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Piesche. The network helps show where Matthias Piesche may publish in the future.

Co-authorship network of co-authors of Matthias Piesche

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Piesche. A scholar is included among the top collaborators of Matthias Piesche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Piesche. Matthias Piesche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Huntington, Kelsey E., Lindsey Carlsen, Eui‐Young So, et al.. (2022). Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity. Pharmaceuticals. 15(5). 618–618. 18 indexed citations
4.
Oliva, Carolina A., Karen Castillo, María C. Maldifassi, et al.. (2021). Effects of Interleukin-1β in Glycinergic Transmission at the Central Amygdala. Frontiers in Pharmacology. 12. 613105–613105. 5 indexed citations
5.
Carvacho, Ingrid & Matthias Piesche. (2021). RGD‐binding integrins and TGF‐β in SARS‐CoV‐2 infections – novel targets to treat COVID‐19 patients?. Clinical & Translational Immunology. 10(3). e1240–e1240. 28 indexed citations
6.
Herrada, Andrés A., et al.. (2021). Adipose tissue macrophages as a therapeutic target in obesity‐associated diseases. Obesity Reviews. 22(6). e13200–e13200. 31 indexed citations
7.
Piesche, Matthias, Jessica Roos, Benjamin Kühn, et al.. (2020). The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer. Frontiers in Pharmacology. 11. 1297–1297. 34 indexed citations
8.
Carvacho, Ingrid, Matthias Piesche, Thorsten J. Maier, & Khaled Machaca. (2018). Ion Channel Function During Oocyte Maturation and Fertilization. Frontiers in Cell and Developmental Biology. 6. 63–63. 38 indexed citations
9.
Zhou, Jun, Kathleen M. Mahoney, Anita Giobbie‐Hurder, et al.. (2017). Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade. Cancer Immunology Research. 5(6). 480–492. 284 indexed citations
10.
Wu, Xinqi, Jingjing Li, Xiaoyun Liao, et al.. (2017). Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes. Cancer Immunology Research. 5(6). 446–454. 58 indexed citations
11.
Ho, Vincent T., Haesook T. Kim, Martín C. Mihm, et al.. (2017). Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT. Blood Advances. 1(24). 2269–2279. 17 indexed citations
12.
Curry, William T., Matthias Piesche, Tetsuro Sasada, et al.. (2016). Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma. Clinical Cancer Research. 22(12). 2885–2896. 45 indexed citations
13.
Roos, Jessica, Sabine Grösch, Oliver Werz, et al.. (2015). Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?. Pharmacology & Therapeutics. 157. 43–64. 29 indexed citations
14.
Piesche, Matthias, Vincent T. Ho, Haesook Kim, et al.. (2014). Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions. Clinical Cancer Research. 21(5). 1010–1018. 10 indexed citations
15.
Piesche, Matthias, York Hildebrandt, Bjoern Chapuy, et al.. (2009). Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3. Vaccine. 27(34). 4718–4723. 4 indexed citations
16.
Piesche, Matthias, York Hildebrandt, Florian Zettl, et al.. (2007). Identification of a promiscuous HLA DR–restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin. Human Immunology. 68(7). 572–576. 17 indexed citations
17.
Wolff, Sonja, Martin Stöter, Georgios Giamas, et al.. (2006). Casein kinase 1 delta (CK1δ) interacts with the SNARE associated protein snapin. FEBS Letters. 580(27). 6477–6484. 24 indexed citations
18.
Schroers, Roland, York Hildebrandt, Justin Hasenkamp, et al.. (2004). Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors. Experimental Hematology. 32(6). 536–546. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yulan Qing Breakdown of academic impact, for papers by Oihana Murillo Breakdown of academic impact, for papers by Kumar S. Bishnupuri Breakdown of academic impact, for papers by Justina McEvoy Breakdown of academic impact, for papers by Neele Schumacher Breakdown of academic impact, for papers by Shingo Eikawa Breakdown of academic impact, for papers by Natasha K. Brockwell Breakdown of academic impact, for papers by Alaa Kassim Ali Breakdown of academic impact, for papers by Minghao Zhong Breakdown of academic impact, for papers by Léa Tourneur
Rankless by CCL
2026